Jump to Content
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Subjects
Clinical Resources
(932)
Drug Information
(932)
Refine by Access
All content
Content accessible to me
Refine by Type
Books
(3)
Chapters
(929)
Submit
Refine by Date
From
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
—
To
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://publications.ashp.org/collection/DrugInfo?access=all&page=9&pageSize=50&sort=datedescending&t=ClinicalResources&t_1=DrugInfo
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
Browse
You are looking at
401
-
450
of
932
items for
:
Clinical Resources
x
Drug Information
x
Refine by Access: All content
x
Clear All
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
4
5
6
7
8
9
10
11
12
13
14
...
Restricted access
Nitrofurantoin Suspension 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Nizatidine Solution 2.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Olmesartan Medoxomil Suspension 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Omeprazole Solution 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Omeprazole Suspension 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ondansetron Hydrochloride Suspension 0.8 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ondansetron Hydrochloride Suspension 0.8 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Oseltamivir Phosphate Suspension 6 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Oseltamivir Phosphate Syrup 15 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Oseltamivir Phosphate Syrup 6 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Oxandrolone Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Oxandrolone Suspension 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Oxandrolone Suspension 3 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pantoprazole Solution 2 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pantoprazole Solution 2 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Penicillamine-D Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pentoxifylline Solution 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Phenobarbital Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Phenobarbital Suspension 15 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Phenobarbital Suspension 9.3 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Phenobarbital Suspension 9 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Phenoxybenzamine Hydrochloride Solution 2 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Phenytoin Suspension 15 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Potassium Chloride Syrup 1 mEq/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Prednisolone Disodium Phosphate Solution 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Prednisolone Sodium Phosphate Suspension 1.4 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Prednisone Syrup 0.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pregabalin Suspension 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Procainamide Hydrochloride Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Propranolol Hydrochloride Suspension 0.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Propranolol Hydrochloride Suspension 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Propranolol Hydrochloride Suspension 5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Propylthiouracil Suspension 5 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Propylthiouracil Suspension 5 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pyrazinamide Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pyrazinamide Suspension 100 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pyrazinamide Syrup 100 mg/mL*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pyridoxine Hydrochloride Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pyrimethamine Suspension 2 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Pyrimethamine Suspension 2 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Quinapril Syrup 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Quinidine Sulfate Suspension 10 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Quinidine Sulfate Suspension 10 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Riboflavin Suspension 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Rifabutin Suspension 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Rifampin Suspension 25 mg/mL—Formulation 1*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Rifampin Suspension 25 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Rifampin Syrup 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Rifaximin Suspension 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Rosuvastatin Suspension 4 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
4
5
6
7
8
9
10
11
12
13
14
...
[18.97.14.90]
18.97.14.90